Panacea Biotec Receives Demand Order for ₹22.88 Crore

Panacea Biotec Receives Demand Order for ₹22.88 Crore

Panacea Biotec Receives Demand Order for ₹22.88 Crore​

Panacea Biotec Limited announced it received a Demand Order dated March 30, 2026, from the Office of the Joint Commissioner, Central Goods & Services Tax (CGST) Sub-Commissionerate Mohali, Chandigarh. The demand aggregates to approximately ₹22.88 crore, encompassing ₹11.44 crore for alleged non-payment of Goods and Services Tax and ₹11.44 crore in penalties.

The demand stems from a previous Show Cause Notice received on September 27, 2025, concerning the alleged non-payment of GST on a corporate guarantee of ₹864 crore provided for 1,074 days, from April 6, 2019, to March 15, 2022. The company filed a writ petition with the Punjab & Haryana High Court in November 2025, which has granted an interim stay order preventing coercive action against the company. Panacea Biotec also submitted a response to the Show Cause Notice on March 27, 2026.

According to the company, the demand is not maintainable, and they will take necessary steps. The company does not anticipate a relevant impact on its financial, operational or other activities.



Details of the Demand Order:

ParticularsDetails
Name of the Listed EntityPanacea Biotec Limited
Date of Receipt of CommunicationMarch 30, 2026
Demand Amount~₹22.88 Crore (₹11.44 Crore GST + ₹11.44 Crore Penalty)
Period of Alleged Non-PaymentApril 6, 2019 to March 15, 2022
Actions TakenFiled a writ petition with the Punjab & Haryana High Court; submitted response to Show Cause Notice

Source:​

 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Last edited by a moderator:
Back
Top